Malaria News and Research

Latest Malaria News and Research

UCF researcher develops first dual vaccine to fight malaria and cholera

A University of Central Florida biomedical researcher has developed what promises to be the first low-cost dual vaccine against malaria and cholera.

27 Jan 2010

Twenty nations meet in Montreal to discuss Haiti recovery; Haitian officials increase Port-Au-Prince death toll estimate

Officials from 20 countries are meeting in Montreal, Canada, Monday "to discuss long-term reconstruction and arrangements for a donor conference to be held in March," the U.N. said, Bloomberg reports (Gaouette/Craze, 1/25). "U.S. Secretary of State Hillary Clinton, Canadian Prime Minister Stephen Harper, French Foreign Minister Bernard Kouchner and others will examine eventual debt forgiveness and" a strategy for rebuilding Haiti at the one-day gathering, according to Reuters (Palmer, 1/25).

27 Jan 2010

Over 125M pregnant women worldwide exposed to malaria annually, study finds

More than 125 million pregnant women worldwide are exposed to malaria each year, according to a study published Tuesday in PLoS Medicine, ANI/oneindia reports. Previously, such estimates were limited to malaria risk in Africa. "Most malarial deaths are among young children in sub-Saharan Africa but pregnant women and their unborn babies are at high risk," the news service writes, adding that "[n]early 10,000 women and 200,000 babies die every year because of malaria in pregnancy, which often leads to miscarriages, pre-term births, and low-birth-weight births" (1/26).

27 Jan 2010

Bill Gates' annual letter highlights innovations aimed at combating disease, hunger and poverty

Bill Gates, co-chair of the Bill & Melinda Gates Foundation, today released his second annual letter -- a personal appraisal of the foundation's efforts to date and how innovation impacts priorities of the foundation.

25 Jan 2010

Recent releases in global health

"Picture the situation in Haiti: families living on top of sewage-contaminated rubbish dumps, with no reliable sources of food and water and virtually no access to health care. This scenario depicts the situation in Haiti before the earthquake that catapulted this impoverished and conflict-ridden country into the international headlines,"

23 Jan 2010

Data from GenVec's trial in esophageal cancer showcased at 2010 Gastrointestinal Cancer Symposium

GenVec, Inc. announced today that data from the Company's trial in esophageal cancer were presented at the American Society of Clinical Oncology's 2010 Gastrointestinal Cancer Symposium in Orlando, Florida on January 22, 2010.

22 Jan 2010

GSK announces new initiatives for addressing healthcare challenges in the world's poorest countries

Andrew Witty, Chief Executive of GlaxoSmithKline, today announced a series of new initiatives targeted at further transforming the company's approach to diseases that disproportionately affect the world's poorest countries. His announcements build on commitments made in 2009 to work in partnership, expand access to medicines and encourage new research into neglected tropical diseases.

22 Jan 2010

Reuters examines chronic disease in developing countries, future of drug prices

"Global health projections leave little doubt that chronic diseases are rapidly overtaking infectious diseases, such as malaria, AIDS and tuberculosis (TB), as the world's biggest killers - a shift emphasized by a recent World Health Organization (WHO) report on global health risks," Reuters writes in a story analyzing the future of drug pricing in the developing world. Longer life-spans in developing countries "and changing patterns of food, alcohol and tobacco consumption are creating a 'double burden' for poor nations, piling chronic diseases on top of infectious diseases," the news service writes.

21 Jan 2010

Global health community to be engaged in using resources of GSK and Alnylam IP Pool

BIO Ventures for Global Health, GlaxoSmithKline (GSK), and Alnylam announced today that the organizations are partnering to engage the global health community in using the powerful resources of the GSK and Alnylam Intellectual Property (IP) Pool.

21 Jan 2010

GSK to offer scientists access to compounds, lab space to fight malaria

Drugmaker GlaxoSmithKline (GSK)'s Chief Executive Officer Andrew Witty on Tuesday unveiled the company's plans to allow "free access to its library of 13,500 potential malaria treatments and devote the profits from its experimental [RTS,S] vaccine to battling tropical illnesses that beset poor countries," Bloomberg reports (Randall, 1/20).

21 Jan 2010

Boston University School of Public Health explores changing global health system for malaria research

This week PLoS Medicine publishes the third in a four-part series of policy papers examining the ways in which global health institutions and arrangements are changing and evolving.

20 Jan 2010

UCI finding could complicate quest to eradicate deadly disease in humans

Chimpanzees were known to carry the parasite Plasmodium reichenowi, but most scientists assumed the two parasites had existed separately in humans and chimpanzees for the last 5 million years.

20 Jan 2010

Media outlets examine efforts to develop malaria vaccines

Scientists have identified a group of proteins they say could form the basis of a malaria vaccine, Australia's ABC News reports. "However, they say more laboratory work and clinical trials need to be done, with a vaccine at least 10 years away," the news service reports (Macey, 1/19).

20 Jan 2010

Rescue, relief efforts continue in Haiti, 200,000 people estimated to have perished in quake

Rescue efforts continue in Haiti after a major earthquake hit the country last week, CNN reports (1/18). While teams still search for survivors under the rubble, the priority is shifting to relief for those who survived the quake, according to Nicholas Reader, spokesperson for the U.N. Offices for the Coordination of Humanitarian Affairs, TIME reports (Newton-Small, 1/18).

20 Jan 2010

Global health care errors, fraud costs $260b annually, report finds

A report released Monday finds $260 billion - or 5.59 percent of annual global health spending - is lost annually to health care errors and fraud, Reuters reports. For the study, the European Healthcare Fraud and Corruption Network (EHFCN) and the Center for Counter Fraud Services (CCFS) at Britain's Portsmouth University, "reviewed 69 exercises in 33 organizations in six countries to measure healthcare fraud and error losses," the news service reports.

20 Jan 2010

GenVec and Novartis collaborate to develop novel treatments for hearing loss and balance disorders

GenVec and Novartis will collaborate to discover and develop novel treatments for hearing loss and balance disorders. Preclinical results suggest that delivery of the atonal gene using GenVec's innovative adenovector technology may have the potential to restore hearing and balance function.

19 Jan 2010

Genetic map of Artemisia will accelerate breeding to address increased demand for malaria treatments

Plant scientists at the University of York have published the first genetic map of the medicinal herb Artemisia annua. The map is being used to accelerate plant breeding of Artemisia and rapidly develop the species into a high-yielding crop. This development is urgently needed to help meet escalating demand for effective malaria treatments.

19 Jan 2010

New findings support the development of vaccine against malaria

Walter and Eliza Hall Institute researchers have uncovered a group of proteins that could form the basis of an effective vaccine against malaria.

19 Jan 2010

New book on harnessing science and innovation to tackle challenges in poor countries

Science and Innovation for Development demonstrates how science and innovation can be harnessed to tackle today's biggest challenges in poor countries, including climate change, HIV/AIDS and illiteracy. Case studies are described, including the use of tissue culture to develop disease-resistant bananas in Kenya; the use of nanotechnology to develop cheaper and faster kits for diagnosing infectious diseases and the use of organic material to power a multi-purpose stove that can also function as a refrigerator and generator.

18 Jan 2010

Penn State receives $1.9M grant to study the effects of climate change on the spread of infectious diseases

The potential effects of climate change on the spread of infectious diseases, such as malaria and dengue fever, are the focus of a nearly $1.9 million grant from the National Science Foundation intended to further the studies of a Penn State-led group of researchers.

18 Jan 2010

Malaria News and Research

Latest Malaria News and Research

UCF researcher develops first dual vaccine to fight malaria and cholera

Twenty nations meet in Montreal to discuss Haiti recovery; Haitian officials increase Port-Au-Prince death toll estimate

Over 125M pregnant women worldwide exposed to malaria annually, study finds

Bill Gates' annual letter highlights innovations aimed at combating disease, hunger and poverty

Recent releases in global health

Data from GenVec's trial in esophageal cancer showcased at 2010 Gastrointestinal Cancer Symposium

GSK announces new initiatives for addressing healthcare challenges in the world's poorest countries

Reuters examines chronic disease in developing countries, future of drug prices

Global health community to be engaged in using resources of GSK and Alnylam IP Pool

GSK to offer scientists access to compounds, lab space to fight malaria

Boston University School of Public Health explores changing global health system for malaria research

UCI finding could complicate quest to eradicate deadly disease in humans

Media outlets examine efforts to develop malaria vaccines

Rescue, relief efforts continue in Haiti, 200,000 people estimated to have perished in quake

Global health care errors, fraud costs $260b annually, report finds

GenVec and Novartis collaborate to develop novel treatments for hearing loss and balance disorders

Genetic map of Artemisia will accelerate breeding to address increased demand for malaria treatments

New findings support the development of vaccine against malaria

New book on harnessing science and innovation to tackle challenges in poor countries

Penn State receives $1.9M grant to study the effects of climate change on the spread of infectious diseases

Pharmaceutical Manufacturing - Industry Focus eBook eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Malaria News and Research

Latest Malaria News and Research

Pharmaceutical Manufacturing - Industry Focus eBook eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in